(Q61907879)
Statements
A Trial to Demonstrate Bioequivalence Between Semaglutide Formulations for the DV3372 Device and the Formulation for the PDS290 Semaglutide Pen-injector (English)
0 references
23 July 2018
0 references
17 January 2019
0 references
68
0 references
18 year
0 references
55 year
0 references